Spots Global Cancer Trial Database for A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies
Official Title: A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies
Study ID: NCT00207025
Conditions
Interventions
Study Description
Brief Summary: The purpose of this clinical research study is to learn about the safety and tolerability of daily BMS-275183 in patients with advanced cancer.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Local Institution, Detroit, Michigan, United States
Local Institution, Pittsburgh, Pennsylvania, United States
Local Institution, Brussels, , Belgium
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
